Israel Active

One of the more unusual studies by scientists at Israel’s Weizmann Institute has uncovered that humans imitate one of the habits of dogs; by sniffing the odor of someone they meet. They do this by subconsciously sniffing their own hand after shaking the other person’s.

Israel’s Vectorious Medical has raised $5 million to take its miniature wireless hemodynamic monitoring sensory implant into human trials. The device measures and reports left atria pressure - a reliable early indication of cardiac deterioration, which medication can treat.

Israel’s SHL Telemedicine specializes in providing remote diagnosis and monitoring services for patients suffering from chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD). Its second German acquisition in two years is GPH, which monitors 10,000 heart patients.

Israeli start-up DeepOptics has developed electronic multifocal lenses. Using sensors, they detect what the eye is focusing on as well as the viewing distance - adjusting the power of your spectacles to ensure that whatever is being looked at comes into focus, whether near or far.

The term “sound asleep” is very appropriate to the discovery by Ben Gurion University researchers of a simple, cheap way to evaluate sleep disorders. Using their innovative breath sound analysis (BSA) algorithm, patients with sleep quality, snoring and sleep apnea problems can be analyzed easily.

The robotic dispensing system from Israel’s RescueDose makes the preparation and administration of liquid medication safer by adding accurate doses automatically and minimizing human contact. RescueDose is already used to dispense radiation treatments for cancer patients.

Great praise from US congressman Chaka Fattah – the man in charge of appropriating federal money for science and medical research and development programs. Fattah, was a keynote speaker at BrainTech 2015 event in Tel Aviv. Per capita, Israel leads the world in neuroscience.

Israel’s Advanced Inhalation Therapies (Beyond Air) has been granted Orphan status by the US FDA to complete the development of its nitric oxide (NO) treatment for cystic fibrosis. The NO gas boosts the body’s immune system, improves blood flow and circulation and kills bacteria, viruses, parasites and fungi.

Stem cells from Israel’s Pluristem have been used in clinical tests to successfully treat bone marrow failure following total body exposure to high doses of radiation.

Scientists at Israel’s Technion together with MIT and Harvard have discovered that chemotherapeutics, delivered in tiny silicon containers with nano-sized holes are able to destroy malignant tumors, whilst avoiding adverse effects on healthy tissue.